BD invests $10M+ to expand U.S. manufacturing of syringes and needles

BD (Becton, Dickinson and Company) announced additional investments in its U.S. manufacturing network, including over $10 million in 2024 to install new needle and syringe production lines at plants in Connecticut and Nebraska, adding hundreds of millions of units annually and hiring more than 215 employees. The company also plans over $30 million in 2025 investments to expand IV line capacity at its Utah plant.

“As part of the company's 2024 investment of more than $10 million to expand manufacturing capacity, new needle and syringe production lines have been installed at the BD plants in Connecticut and Nebraska.”news.bd.com

• 2 sources
• news.bd.comBD Boosts U.S. Manufacturing of Critical Medical Devices - Jan 15, 2025Jan 15, 2025
• respiratory-therapy.comBD Boosts US Manufacturing of Critical Medical Devices | RTRT StaffFeb 12, 2025

Summarized from public sources; check the original articles before acting on it.